Crescioli, Elena https://orcid.org/0000-0002-8267-7634
Nielsen, Frederik Mølgaard https://orcid.org/0000-0002-0071-1203
Bunzel, Anne-Marie https://orcid.org/0009-0002-9639-0623
Eriksen, Anne Sofie Broberg https://orcid.org/0009-0008-6540-1995
Siegemund, Martin https://orcid.org/0000-0002-2013-4140
Poulsen, Lone Musaeus https://orcid.org/0000-0002-7030-3395
Andreasen, Anne Sofie https://orcid.org/0000-0002-8759-3405
Bestle, Morten Heiberg https://orcid.org/0000-0001-6585-2659
Iversen, Susanne Andi
Brøchner, Anne Craveiro https://orcid.org/0000-0001-6453-6152
Grøfte, Thorbjørn
Hildebrandt, Thomas
Laake, Jon Henrik https://orcid.org/0000-0001-6157-5359
Kjær, Maj-Brit Nørregaard https://orcid.org/0000-0002-6536-0504
Lange, Theis https://orcid.org/0000-0001-6807-8347
Perner, Anders https://orcid.org/0000-0002-4668-0123
Klitgaard, Thomas Lass https://orcid.org/0000-0002-8781-1206
Schjørring, Olav Lilleholt https://orcid.org/0000-0002-7749-6003
Rasmussen, Bodil Steen https://orcid.org/0000-0003-2190-145X
Clinical trials referenced in this document:
Documents that mention this clinical trial
Long-term mortality and health-related quality of life with lower versus higher oxygenation targets in intensive care unit patients with COVID-19 and severe hypoxaemia
https://doi.org/10.1007/s00134-024-07613-2
Funding for this research was provided by:
Uddannelses- og Forskningsministeriet
Research Council, Aalborg University Hospital
Aalborg University Hospital
Article History
Received: 18 May 2024
Accepted: 12 August 2024
First Online: 5 September 2024
Declarations
:
: The Department of Intensive Care at Rigshospitalet (AP, MNK) received funding from Sygeforsikringen “Danmark”, The Novo Nordisk Foundation, the Ehrenreich Foundation, the Becketts Foundation, and AM-Pharma. TL has served in Data and Safety Monitoring Board for Novo Nordisk and Leo Pharma, respectively: the studies were unrelated to the present study.
: Consent was obtained from patients or legal surrogates according to applicable laws and regulations. Enrolment according to an emergency procedure (i.e., consent from a doctor independent of the trial followed by consent from relatives and/or patients) was allowed at many sites; additional details were presented in the primary report [].